Literature DB >> 19188760

Association between CpG island methylation of the WWOX gene and its expression in breast cancers.

X Wang1, L Chao, G Jin, G Ma, Y Zang, J Sun.   

Abstract

OBJECTIVES: The aim of the present study was to evaluate the expression of the WWOX gene in breast carcinoma and to analyze the relationship between its expression and methylation.
METHODS: Methylation of the WWOX promoter and exon 1 as well as WWOX expression were determined by methylation-specific PCR, reverse transcription PCR and immunohistochemistry in 20 breast cancer tissue samples and corresponding nonneoplastic tissues. The expression of WWOX protein was evaluated by immunohistochemistry in 2 breast cancer cell lines.
RESULTS: WWOX mRNA expression was reduced in breast cancer tissues as compared to adjacent tissues (p < 0.001). WWOX mRNA and protein expression was significantly reduced in breast cancer tissues with methylated WWOX CpG islands when compared to tissues without methylation (p < 0.001 and p = 0.008, respectively). Immunohistochemical analysis also showed that WWOX levels were significantly decreased in tissues with WWOX methylation (p = 0.001). WWOX mRNA and protein expression was greatly reduced in MDA-MB-231 cells, partly due to the methylation of WWOX CpG islands, and recovered after hydralazine treatment.
CONCLUSIONS: Differential regulation of the WWOX gene plays an important role in the carcinogenesis of breast cancer, due partially to methylation of the WWOX DNA CpG islands. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188760     DOI: 10.1159/000197911

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  11 in total

Review 1.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

2.  WW domain containing oxidoreductase induces apoptosis in gallbladder-derived malignant cell by upregulating expression of P73 and PUMA.

Authors:  Dong Wei; Xiaowen Zhang; Hao Zou; Lin Wang; Bimang Fu; Xuesong Wu; Zhiling Luo; Xiao Li; Jiayun Ge; Yuehua Li; Hong Zhu; Kun Wang; Tao Wang; Pei Yang; Zongliu Hou; Wenju Wang
Journal:  Tumour Biol       Date:  2013-10-15

3.  Genetic alterations of the WWOX gene in breast cancer.

Authors:  Seda Ekizoglu; Mahmut Muslumanoglu; Nejat Dalay; Nur Buyru
Journal:  Med Oncol       Date:  2011-10-08       Impact factor: 3.064

4.  WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC).

Authors:  Onur Baykara; Ahmet Demirkaya; Kamil Kaynak; Serhan Tanju; Alper Toker; Nur Buyru
Journal:  Tumour Biol       Date:  2010-05-18

5.  Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Hiroshi Handa; Yoshiko Sasaki; Hikaru Hattori; Lobna Alkebsi; Tetsuhiro Kasamatsu; Takayuki Saitoh; Takeki Mitsui; Akihiko Yokohama; Norifumi Tsukamoto; Morio Matsumoto; Hirokazu Murakami
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

Review 6.  Alteration of WWOX in human cancer: a clinical view.

Authors:  Izabela Baryła; Ewa Styczeń-Binkowska; Andrzej K Bednarek
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-13

7.  A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results.

Authors:  Jaime Coronel; Lucely Cetina; Irlanda Pacheco; Catalina Trejo-Becerril; Aurora González-Fierro; Erick de la Cruz-Hernandez; Enrique Perez-Cardenas; Lucia Taja-Chayeb; Daymi Arias-Bofill; Myrna Candelaria; Silvia Vidal; Alfonso Dueñas-González
Journal:  Med Oncol       Date:  2010-10-08       Impact factor: 3.064

8.  DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells.

Authors:  Myrna Candelaria; Erick de la Cruz-Hernandez; Lucia Taja-Chayeb; Enrique Perez-Cardenas; Catalina Trejo-Becerril; Aurora Gonzalez-Fierro; Alma Chavez-Blanco; Ernesto Soto-Reyes; Guadalupe Dominguez; Jaenai E Trujillo; Jose Diaz-Chavez; Alfonso Duenas-Gonzalez
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

Review 9.  WWOX Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future Directions.

Authors:  Karolina Pospiech; Elzbieta Płuciennik; Andrzej K Bednarek
Journal:  Front Oncol       Date:  2018-08-28       Impact factor: 6.244

10.  Effects of 5-Aza-2'-deoxycytidine on the methylation state and function of the WWOX gene in the HO-8910 ovarian cancer cell line.

Authors:  Hongchao Yan; Nan Yu; Jianye Tong
Journal:  Oncol Lett       Date:  2013-07-03       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.